KeySource Acquisition operates as a 3PL with FDA registration and maintains active wholesale drug licenses in 49 states, though nearly half of its total licenses (38 of 74) have lapsed. The company demonstrates solid DSCSA compliance and a clean regulatory record with no FDA recalls or warning letters, but lacks both NABP accreditation and DEA registration, limiting its ability to handle controlled substances in the supply chain.